Anti-TNF-alpha agents in the treatment of psoriatic arthritis.
about
Predictors of infusion reactions during infliximab treatment in patients with arthritis.Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.Immunomodulating Drugs Based on Poxviral Proteins.Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors.Effective Therapy with Anti-TNF- in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin Lesions
P2860
Anti-TNF-alpha agents in the treatment of psoriatic arthritis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Anti-TNF-alpha agents in the treatment of psoriatic arthritis.
@ast
Anti-TNF-alpha agents in the treatment of psoriatic arthritis.
@en
type
label
Anti-TNF-alpha agents in the treatment of psoriatic arthritis.
@ast
Anti-TNF-alpha agents in the treatment of psoriatic arthritis.
@en
prefLabel
Anti-TNF-alpha agents in the treatment of psoriatic arthritis.
@ast
Anti-TNF-alpha agents in the treatment of psoriatic arthritis.
@en
P2860
P356
P1476
Anti-TNF-alpha agents in the treatment of psoriatic arthritis.
@en
P2093
Jan Brandt
Jürgen Braun
P2860
P304
P356
10.1517/14712598.6.2.99
P407
P577
2006-02-01T00:00:00Z